Brand Name: COSOVIR-SV
Generic Name: Sofosbuvir & Velpatasvir Tablets
Available Strengths:
Sofosbuvir 400mg & Velpatasvir 100mg
Sofosbuvir & Velpatasvir Tablets are a fixed-dose combination antiviral therapy used for the treatment of chronic Hepatitis C virus (HCV) infection across all major genotypes (1–6). Sofosbuvir, a nucleotide polymerase inhibitor, stops the virus from multiplying, while Velpatasvir, an NS5A inhibitor, prevents viral replication and assembly. Together, they deliver a highly effective, all-oral regimen with excellent sustained virologic response (SVR) rates. This combination helps reduce viral load rapidly, promotes liver recovery, and prevents complications such as cirrhosis and liver cancer. Treatment should be taken strictly under medical supervision, following the prescribed dosage and duration for best results.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com